226 related articles for article (PubMed ID: 33639937)
1. Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation.
Heydt C; Wölwer CB; Velazquez Camacho O; Wagener-Ryczek S; Pappesch R; Siemanowski J; Rehker J; Haller F; Agaimy A; Worm K; Herold T; Pfarr N; Weichert W; Kirchner T; Jung A; Kumbrink J; Goering W; Esposito I; Buettner R; Hillmer AM; Merkelbach-Bruse S
BMC Med Genomics; 2021 Feb; 14(1):62. PubMed ID: 33639937
[TBL] [Abstract][Full Text] [Related]
2. CANTRK: A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA Sequencing.
Stockley TL; Lo B; Box A; Corredor AG; DeCoteau J; Desmeules P; Feilotter H; Grafodatskaya D; Greer W; Hawkins C; Huang WY; Izevbaye I; Lépine G; Martins Filho SN; Papadakis AI; Park PC; Riviere JB; Sheffield BS; Spatz A; Spriggs E; Tran-Thanh D; Yip S; Zhang T; Torlakovic E; Tsao MS
J Mol Diagn; 2023 Mar; 25(3):168-174. PubMed ID: 36586421
[TBL] [Abstract][Full Text] [Related]
3. Comparison of four next generation sequencing platforms for fusion detection: Oncomine by ThermoFisher, AmpliSeq by illumina, FusionPlex by ArcherDX, and QIAseq by QIAGEN.
Qu X; Yeung C; Coleman I; Nelson PS; Fang M
Cancer Genet; 2020 May; 243():11-18. PubMed ID: 32197218
[TBL] [Abstract][Full Text] [Related]
4. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.
Velizheva NP; Rechsteiner MP; Valtcheva N; Freiberger SN; Wong CE; Vrugt B; Zhong Q; Wagner U; Moch H; Hillinger S; Schmitt-Opitz I; Soltermann A; Wild PJ; Tischler V
Pathol Res Pract; 2018 Apr; 214(4):572-578. PubMed ID: 29580750
[TBL] [Abstract][Full Text] [Related]
5. Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
Pfarr N; Kirchner M; Lehmann U; Leichsenring J; Merkelbach-Bruse S; Glade J; Hummel M; Stögbauer F; Lehmann A; Trautmann M; Kumbrink J; Jung A; Dietmaier W; Endris V; Kazdal D; Evert M; Horst D; Kreipe H; Kirchner T; Wardelmann E; Lassen U; Büttner R; Weichert W; Dietel M; Schirmacher P; Stenzinger A
Genes Chromosomes Cancer; 2020 Mar; 59(3):178-188. PubMed ID: 31652375
[TBL] [Abstract][Full Text] [Related]
6. Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study.
Kumar S; Bennett A; Campbell PA; Palidwor G; Lo B; Perkins TJ; Nochaiwong S; Sekhon HS; Stewart DJ; Thavorn K
Curr Oncol; 2022 Jul; 29(8):5238-5246. PubMed ID: 35892985
[No Abstract] [Full Text] [Related]
7. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
[TBL] [Abstract][Full Text] [Related]
8. Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.
Kim B; Lee H; Shin S; Lee ST; Choi JR
J Mol Diagn; 2019 Jan; 21(1):163-170. PubMed ID: 30347268
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of an RNA Sequencing Assay for Gene Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tumors.
Peng H; Huang R; Wang K; Wang C; Li B; Guo Y; Li M; Zhang D; Dong H; Chen H; Chen C; Xu Q; Li F; Tian L; Wu J
J Mol Diagn; 2021 Feb; 23(2):223-233. PubMed ID: 33271368
[TBL] [Abstract][Full Text] [Related]
10. Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.
Lindquist KE; Karlsson A; Levéen P; Brunnström H; Reuterswärd C; Holm K; Jönsson M; Annersten K; Rosengren F; Jirström K; Kosieradzki J; Ek L; Borg Å; Planck M; Jönsson G; Staaf J
Oncotarget; 2017 May; 8(21):34796-34810. PubMed ID: 28415793
[TBL] [Abstract][Full Text] [Related]
11. The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing.
Guseva NV; Tanas MR; Stence AA; Sompallae R; Schade JC; Bossler AD; Bellizzi AM; Ma D
Cancer Genet; 2016; 209(7-8):303-12. PubMed ID: 27292373
[TBL] [Abstract][Full Text] [Related]
12. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.
Claerhout S; Lehnert S; Vander Borght S; Spans L; Dooms C; Wauters E; Vansteenkiste J; Weynand B; Deraedt K; Bourgain C; Vanden Bempt I
Lung Cancer; 2022 Apr; 166():242-249. PubMed ID: 35378489
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Targeted Next-Generation Sequencing Assays and Reference Materials for NTRK Fusion Detection.
Bormann Chung C; Lee J; Barritault M; Bringuier PP; Xu Z; Huang WY; Beharry A; Castillo J; Christiansen J; Lin JC; Sheffield BS
J Mol Diagn; 2022 Jan; 24(1):18-32. PubMed ID: 34656759
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid Tumors.
Heydt C; Ruesseler V; Pappesch R; Wagener S; Haak A; Siebolts U; Riedel R; Michels S; Wolf J; Schultheis AM; Rehker J; Buettner R; Merkelbach-Bruse S
J Mol Diagn; 2019 Nov; 21(6):971-984. PubMed ID: 31382035
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
16. Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing-Based NTRK Fusion Detection in South Korea.
Lee SE; Lee MS; Jeon YK; Shim HS; Kang J; Kim J; Choi YL
Cancer Res Treat; 2023 Jan; 55(1):28-40. PubMed ID: 35167738
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study.
Vaughn CP; Costa JL; Feilotter HE; Petraroli R; Bagai V; Rachiglio AM; Marino FZ; Tops B; Kurth HM; Sakai K; Mafficini A; Bastien RRL; Reiman A; Le Corre D; Boag A; Crocker S; Bihl M; Hirschmann A; Scarpa A; Machado JC; Blons H; Sheils O; Bramlett K; Ligtenberg MJL; Cree IA; Normanno N; Nishio K; Laurent-Puig P
BMC Cancer; 2018 Aug; 18(1):828. PubMed ID: 30115026
[TBL] [Abstract][Full Text] [Related]
18. Comparison of RNA-Based Next-Generation Sequencing Assays for the Detection of NTRK Gene Fusions.
Park HJ; Baek I; Cheang G; Solomon JP; Song W
J Mol Diagn; 2021 Nov; 23(11):1443-1451. PubMed ID: 34756276
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA.
Supplee JG; Milan MSD; Lim LP; Potts KT; Sholl LM; Oxnard GR; Paweletz CP
Lung Cancer; 2019 Aug; 134():96-99. PubMed ID: 31320002
[TBL] [Abstract][Full Text] [Related]
20. FindDNAFusion: An Analytical Pipeline with Multiple Software Tools Improves Detection of Cancer-Associated Gene Fusions from Genomic DNA.
Pan X; Tu H; Mohamed N; Avenarius M; Caruthers S; Zhao W; Jones D
J Mol Diagn; 2024 Feb; 26(2):140-149. PubMed ID: 38008285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]